Risk Factors for Portal Vein Stenosis in Living-Donor Liver Transplantation

Miyagi, Shigehito; Kawagishi, Naoki; Maida, Kai; Nakanishi, Waka; Hara, Yasuyuki; Nakanishi, Chikashi; Takeda, Ikuo; Satoh, Kazushige; Ohuchi, Noriaki; Satoh, Susumu

doi:10.1016/j.transproceed.2013.09.042

Cited by 5 publications

(2 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[10] Different surgical approaches could be employed to reconstruct the portal venous flow depending on the extent of thrombosis, and the availability of collateral vessels. [8] Those treatment methods include endovascular thrombectomy alone, additional PV plasty, PV stenting, interposition graft, or additional interruption of collaterals.…”

Section: Discussionmentioning

confidence: 99%

Left branch of portal vein thrombosis in a liver transplant recipient with donation after cardiac death donor

Chen¹,

Wang²,

Lin

et al. 2016

Medicine

View full text Add to dashboard Cite

Introduction:Portal vein thrombosis (PVT) is one of the most severe complications after liver transplantation, which usually causes graft loss and recipient mortality. The founding of the embolic branch of portal system and its result are not well described in the literature.Clinical findings and diagnoses:We report here an unusual case of complete right branch thrombosis of portal vein after orthotopic liver transplantation from a donation after cardiac death donor, without obvious malaise.The interventions and outcomes:The branch thrombosis of portal vein was detected by Doppler ultrasound 11 days after transplantation, followed by angiography for further verification. After treatment with urgent indwelling catheter thrombolysis with urokinase, results improved and the patient showed stable liver function. The patient has been in remission for 22 months with normal graft function.Conclusion:In this case report, we show that frequent ultrasound inspection should be adopted to detect the unobstructed vessel in the early stage of liver transplantation, and local thrombolytic therapy can be used to prevent liver injury and keep the vessel open.

show abstract

Section: Discussionmentioning

confidence: 99%

Left branch of portal vein thrombosis in a liver transplant recipient with donation after cardiac death donor

Chen¹,

Wang²,

Lin

et al. 2016

Medicine

View full text Add to dashboard Cite

show abstract

“…Jurim (1995) [79] USA R/C LT/RLT 0-10 Not described HAT 29% (LT) vs. 0% (RLT) Kamel (2006) [80] Ireland R/C KT 0-18 None GT 5% Kanmaz (2014) [13] Turkey R/C LT 0-18 ASA HAT 3.9%, PVT 6.8% Karatzas (1997) [81] USA R/C LT All Not described HAT 11.4% Khan (2014) [82] Saudi Arabia R/C KT 0- [86] Italy R/C LT, < 6 kg 0-1 Not described HAT 0%, PVT 6% [12] Switzerland R/C LT 0-18 UFH, ASA, FFP HAT 1.8%, PVT 0.9% Millis (1996) [19] USA R/C LDLT/RLT 0-3 Not described ePVT 4-33%; dPVT 4-51% Miyagi (2014) [88] Japan R/C LDLT All Protease inhibitor Not reported Nagra (2004) [48] UK R/C KT 0-17 UFH vs. No prophylaxis GT 8% vs. 11% Neto (2007) [89] Brazil P/C LDLT < 10 kg 0-18 Not described HAT 3.1%, PVT 5.4% Neto (2012) [10] Brazil P/C LDLT 0-18 Not described HAT 4.3%, ePVT 2.6%, dPVT 5.8% Neto (2014) [90] Brazil P/C LDLT 0-18 UFH/VKA in high risk, dipyridamole PVT 7%…”

Section: Thromboprophylaxismentioning

confidence: 99%

Pediatric transplantation: preventing thrombosis

Robertson

2015

Journal of Thrombosis and Haemostasis

View full text Add to dashboard Cite

Summary Due to progressive advances in surgical techniques, immunosuppressive therapies, and supportive care, outcomes from both solid organ transplantation and hematopoietic stem cell transplantation continue to improve. Thrombosis remains a challenging management issue in this context, with implications for both graft survival and long‐term quality of life. Unfortunately, there remains a general paucity of pediatric‐specific data regarding thrombosis incidence, risk stratification, and the safety or efficacy of preventative strategies with which to guide treatment algorithms. This review summarizes the available evidence and rationale underlying the spectrum of current practices aimed at preventing thrombosis in the transplant recipient, with a particular focus on risk factors, pathophysiology, and described antithrombotic regimens.

show abstract

Therapiemöglichkeiten durch radiologische Interventionen

Trumm

Hoffmann

2015

Komplikationsmanagement in Der Chirurgie

View full text Add to dashboard Cite

Risk Factors for Portal Vein Stenosis in Living-Donor Liver Transplantation

Cited by 5 publications

References 5 publications

Left branch of portal vein thrombosis in a liver transplant recipient with donation after cardiac death donor

Left branch of portal vein thrombosis in a liver transplant recipient with donation after cardiac death donor

Pediatric transplantation: preventing thrombosis

Therapiemöglichkeiten durch radiologische Interventionen

Contact Info

Product

Resources

About